LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.88 | 84.90 | 3875 | 7291 | 0.5314 | 0.8126 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.59 | 84.90 | 361 | 7641 | 0.0472 | 0.2498 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.59 | 84.90 | 3583 | 7641 | 0.4689 | 0.7798 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.59 | 84.90 | 3995 | 7641 | 0.5228 | 0.8098 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.59 | 84.90 | 4076 | 7641 | 0.5334 | 0.8155 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 62.29 | 84.90 | 363 | 7934 | 0.0458 | 0.2485 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 62.29 | 84.90 | 3675 | 7934 | 0.4632 | 0.7782 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 62.29 | 84.90 | 4060 | 7934 | 0.5117 | 0.8054 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 62.29 | 84.90 | 4216 | 7934 | 0.5314 | 0.8159 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.99 | 84.90 | 365 | 8212 | 0.0444 | 0.2475 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.99 | 84.90 | 3831 | 8212 | 0.4665 | 0.7817 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.99 | 84.90 | 4259 | 8212 | 0.5186 | 0.8105 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.99 | 84.90 | 4361 | 8212 | 0.5310 | 0.8170 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.70 | 84.90 | 361 | 8484 | 0.0425 | 0.2435 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.70 | 84.90 | 3949 | 8484 | 0.4655 | 0.7825 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.70 | 84.90 | 4418 | 8484 | 0.5207 | 0.8129 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.70 | 84.90 | 4548 | 8484 | 0.5361 | 0.8208 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.41 | 84.90 | 388 | 8766 | 0.0443 | 0.2550 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.41 | 84.90 | 4145 | 8766 | 0.4728 | 0.7882 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.41 | 84.90 | 4552 | 8766 | 0.5193 | 0.8134 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.41 | 84.90 | 4688 | 8766 | 0.5348 | 0.8214 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.11 | 84.90 | 368 | 8988 | 0.0409 | 0.2437 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.11 | 84.90 | 4242 | 8988 | 0.4720 | 0.7888 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.11 | 84.90 | 4683 | 8988 | 0.5210 | 0.8152 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.11 | 84.90 | 4833 | 8988 | 0.5377 | 0.8238 | MN20160318_Q02 | N04 |